Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Montivilliers – page 2

16 clinical trials in Montivilliers, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Montivilliers at a glance
16
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

16 trials in Montivilliers

Open in trial search

Systemic scleroderma

Not yet recruiting

Rituximab versus placebo for maintenance therapy in adults with stabilized systemic sclerosis‑associated interstitial lung disease

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Assistance Publique Hopitaux De Paris

Axial spondyloarthritis

Not yet recruiting

A study comparing bimekizumab and adalimumab for treating chest pain in patients with active axial spondyloarthritis who do not respond well to non-steroidal anti-inflammatory drugs.

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Adalimumab
  • Sponsor:Centre Hospitalier Universitaire Rouen

Study of the effectiveness of iloprost compared to a placebo for treating vaso-occlusive crises in adults with sickle cell disease

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Centre Hospitalier Universitaire Rouen

Plasma cell myeloma

Not recruiting

Study on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Bortezomib
  • Sponsor:Centre Hospitalier Universitaire De Poitiers

Other cities in France

The busiest research cities in the country

All 382 cities in France

Clinical research in Montivilliers

What the registry says about research in the country

01 Multiple Myeloma Research

Innovative studies focusing on elranatamab-lenalidomide combinations for newly diagnosed multiple myeloma patients, exploring alternatives to traditional chemotherapy and transplant approaches.

  • Consolidation therapy optimization
  • Maintenance treatment evaluation
  • MRD negativity assessment

Additional research examines isatuximab treatment protocols for elderly patients ineligible for transplants.

02 Rheumatoid Arthritis Studies

Comprehensive trials evaluating different treatment approaches for rheumatoid arthritis, including maintenance therapy optimization and comparative effectiveness studies.

  • Rituximab dosing strategies
  • Targeted therapy evaluation
  • Combined treatment protocols

Research comparing the efficacy of triple therapy versus targeted treatments in patients with insufficient response to conventional medications.

03 Therapeutic Innovations

Advanced clinical investigations focusing on developing personalized treatment approaches for both hematologic and autoimmune conditions.

  • Novel drug combinations
  • Age-specific protocols
  • Treatment optimization strategies

Studies aim to improve treatment outcomes while considering patient-specific factors and quality of life measures.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.